Entry Detail



General Information

Database ID:exR0269290
RNA Name:hsa-miR-1224-5p
RNA Type:miRNA
Chromosome:chr3
Starnd:+
Coordinate:
Start Site(bp):184241405End Site(bp):184241423
External Links:hsa-miR-1224-5p



Disease Information

Disease Name:Multiple Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D009103
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Multiple//Sclerosis, Disseminated//Disseminated Sclerosis//MS (Multiple Sclerosis)//Multiple Sclerosis, Acute Fulminating



Expression Detail

GEO ID:GSE140106
Description:Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment
Experimental Design:Fingolimod treatment
Case Disease Type:Multiple Sclerosis
Case Disease SubType:NA
Case Sample:Fingolimod treated Multiple Sclerosis
Control Sample:Untreated
Number of Case:27
Number of Control:27
Number of Samples:54





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ARF3
chr12
48935723
48957487
-
DHCR7
chr11
71428193
71452868
-
ZNF621
chr3
40524878
40574685
+
SEC14L1
chr17
77088749
77217101
+
EMC10
chr19
50476400
50490870
+
RACGAP1
chr12
49976923
50033136
-
THBD
chr20
23045633
23049672
-
ENSA
chr1
150600851
150629612
-
SLC9A3R1
chr17
74748628
74769353
+
STK4
chr20
44966479
45080021
+
LDOC1
chrX
141111605
141177129
-
UBL5
chr19
9827892
9830115
+
HOXB8
chr17
48611377
48615292
-
ANKRD52
chr12
56237807
56258384
-
TRAM2
chr6
52497408
52577060
-
RNF157
chr17
76142465
76240493
-
STC1
chr8
23841929
23854806
-
LMBR1
chr7
156668946
156893216
-
CALU
chr7
128739292
128773400
+
ATP6V1A
chr3
113747033
113812056
+
KIAA1522
chr1
32741830
32774970
+
IKBKB
chr8
42271302
42332653
+
XPO7
chr8
21919662
22006585
+
MIER3
chr5
56919602
56971675
-
DYRK1B
chr19
39825350
39834201
-
TBC1D20
chr20
435480
462543
-
MAPKAPK2
chr1
206684944
206734283
+
OPA3
chr19
45527427
45602212
-
AK2
chr1
33007940
33080996
-
FYCO1
chr3
45917899
45995824
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009133.5
chr16
29808679
29812227
+
AP000766.1
chr11
107312132
107316271
-
NEAT1
chr11
65422774
65445540
+
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE140106
Sample Source:Blood
Source Fraction:Exosome
Platform:GPL11154
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1907
Sample treatment protocol:Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science).
RNA Extract protocol:Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer's protocol.
RNA library preparation protocol:Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer's instructions.



Reference

PMID:31721043
Title:Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment
Author:Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F
Journal:Mol Neurobiol. 2020 Feb;57(2):1245-1258.
Description:we sought the possible utility of serum exosome microRNAs as biomarkers for disease activity in multiple sclerosis patients in response to fingolimod therapy.